Cargando…
TYRO3 agonist as therapy for glomerular disease
Podocyte injury and loss are key drivers of primary and secondary glomerular diseases, such as focal segmental glomerulosclerosis (FSGS) and diabetic kidney disease (DKD). We previously demonstrated the renoprotective role of protein S (PS) and its cognate tyrosine-protein kinase receptor, TYRO3, in...
Autores principales: | Zhong, Fang, Cai, Hong, Fu, Jia, Sun, Zeguo, Li, Zhengzhe, Bauman, David, Wang, Lois, Das, Bhaskar, Lee, Kyung, He, John Cijiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870075/ https://www.ncbi.nlm.nih.gov/pubmed/36454644 http://dx.doi.org/10.1172/jci.insight.165207 |
Ejemplares similares
-
Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease
por: Zhong, Yifei, et al.
Publicado: (2011) -
Global transcriptomic changes in glomerular endothelial cells in mice with podocyte depletion and glomerulosclerosis
por: Fu, Jia, et al.
Publicado: (2021) -
The Beneficial Role of Retinoids in Glomerular Disease
por: Mallipattu, Sandeep K., et al.
Publicado: (2015) -
HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy
por: Chen, Man, et al.
Publicado: (2023) -
The Glomerular Filtration Barrier: Components and Crosstalk
por: Menon, Madhav C., et al.
Publicado: (2012)